Our data showed a trend that RCC patients with positive expression of membranous EGFR had a poorer survival outcome compared with those with negative expression of membranous EGFR (Fig. 4A), although it did not reach statistical significance (P = 0.2). The gene discussed is EGFR; the disease is renal cell adenocarcinoma.